Plain language summary of the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
This is a summary of a clinical study called CARTITUDE-1. This study tested the anti-cancer chimeric antigen receptor-T cell (CAR-T) therapy ciltacabtagene autoleucel, abbreviated as cilta-cel, in people with multiple myeloma, a cancer that affects a specific type of blood cell called plasma cells....
Saved in:
Published in | Future oncology (London, England) Vol. 19; no. 18; pp. 1235 - 1247 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Future Medicine Ltd
01.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!